AGT and triple-A syndrome: A known effect of in vivo AngII‐treatment as an arterial aging model is the high likelihood of abdominal aorta aneurysm (AAA) formation, which involves progressive and irreversible focal dilation of the abdominal aorta that can lead to catastrophic rupture (Raffort et al., 2017).